Precision Isolation of Circulating Leukemia Cells in Chronic Myelogenous Leukemia Patients Using a Novel Microfluidic Device and Its Clinical Applications.

Cancers (Basel) · 2023 · PMC10705219 · PMID 38067399

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

Through statistical analyses, we confirmed the device’s efficacy in differentiating between active disease stages and remission stages, yielding a highly significant p -value of p < 0.0001.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.